A working definition
Patent-to-product mapping connects individual claim limitations to observable product features and preserves the evidence behind each proposed association. It is most useful when the result remains traceable: a reviewer can see the claim language, product version, source, date, confidence and unresolved gaps.
The map is not a legal conclusion. It is an evidence system that helps portfolio, product and legal teams decide where closer review is justified.
What a useful map contains
The core record includes normalized patent families, current claim status, product and model identifiers, limitation-level evidence, source dates and an explicit confidence scale. Negative findings matter too. A blank cell should mean something defined, not simply that research stopped.
When teams use it
Common uses include portfolio-to-product alignment, patent-marking support, licensing preparation, transaction diligence and recurring portfolio reviews. The scope and evidence standard should be tailored to that decision before work begins.
Choose the unit of mapping before the work starts
A family-to-product screen asks where further review is worthwhile. A selected-claim chart asks how individual limitations relate to a particular product version. These are different levels of work. A family may contain claims with different scope, and a product family may include models with materially different features. The brief should identify the unit being compared rather than treating a family name as a coverage conclusion.
Worked example: a changing controller
In our fictional demonstration, Model A has a documented temperature input while Model B has an adaptive-control feature whose implementation remains unclear. The first association has direct support for one limitation; the second needs investigation. Neither establishes that a complete claim is met. The workbook preserves model versions, evidence identifiers and the reason a reviewer has not yet approved an association.
What to ask a provider
Ask whether you will receive the source workbook, how unsupported limitations are recorded, how product revisions are identified and who approves proposed associations. Agree whether the initial output is a research shortlist or a detailed claim-level record. This makes the deliverable easier to use within an existing IP review process.